JAZZJazz Pharmaceuticals plc
JAZZ
Jazz Pharmaceuticals plc4,162
Mkt Cap
$11.64BVolume
11.0052W High
$198.0052W Low
$95.49PE Ratio
-31.68JAZZ Fundamentals
Price
$189.15Prev Close
$189.08Open
$187.1650D MA
$175.49Beta
0.71Avg. Volume
1.09MEPS (Annual)
-$5.84P/B
2.69Rev/Employee
$1.48M$13,352.18
SG Americas Securities LLC Has $23.12 Million Stake in Jazz Pharmaceuticals PLC $JAZZ
SG Americas Securities LLC increased its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 2,969.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 136,024 shares of the...
MarketBeat·2h ago
Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report?
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·19h ago
MassMutual Private Wealth & Trust FSB Sells 7,073 Shares of Jazz Pharmaceuticals PLC $JAZZ
MassMutual Private Wealth & Trust FSB lowered its position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 95.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 353 shares of the specialty pha...
MarketBeat·2d ago
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education American Nutrition Association Announces...
PR Newswire·3d ago
Groupama Asset Managment Lowers Position in Jazz Pharmaceuticals PLC $JAZZ
Groupama Asset Managment decreased its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 70.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,576 shares of the specialty pharmaceutical company's stock after selling 6,142 s...
MarketBeat·5d ago
Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $232.00 Price Target at Piper Sandler
Piper Sandler lifted their target price on Jazz Pharmaceuticals from $219.00 to $232.00 and gave the stock an "overweight" rating in a report on Thursday...
MarketBeat·8d ago
Goldentree Asset Management LP Takes $149.60 Million Position in Jazz Pharmaceuticals PLC $JAZZ
Goldentree Asset Management LP purchased a new stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·8d ago
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026 Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing...
PR Newswire·9d ago
Faithward Advisors LLC Increases Position in Jazz Pharmaceuticals PLC $JAZZ
Faithward Advisors LLC raised its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 93.4% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·9d ago
Holocene Advisors LP Acquires 135,367 Shares of Jazz Pharmaceuticals PLC $JAZZ
Holocene Advisors LP raised its holdings in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Free Report) by 28.8% in the third quarter, according to the company in its most recent Form 13F filing...
MarketBeat·10d ago
<
1
2
...
>